Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer
EAGAN, Minn.--(BUSINESS WIRE)--Jun 4, 2007 - Imprime
investigational new drug from Biothera that enhances the innate
immune system response, increases the effectiveness of Avastin(R)
(bevacizumab) to kill cancer cells, according to new preclinical
research presented yesterday at the 200...